The ability to selectively and precisely ablate biological tissue is a natural candidate for the treatment of cancer, heart disease and HIV.
Remote in vivo molecular specific detection, differentiation and deletion of virus, bacteria, arterial plaque, and numerous differentiated cancers, without collateral damage to contiguous salubrious cells.
Research in transferring and adapting remote molecular specific technologies from U.S. defense and intelligence agencies into medical applications.